Israel Englander’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-339,474
Closed -$1.21M 6211
2026
Q1
$1.21M Buy
339,474
+324,108
+2,109% +$1.33M ﹤0.01% 4259
2025
Q4
$72.5K Buy
+15,366
New +$68.5K ﹤0.01% 5681
2025
Q2
Sell
-75,000
Closed -$196K 6176
2025
Q1
$196K Sell
75,000
-5,666
-7% -$18.3K ﹤0.01% 5312
2024
Q4
$307K Buy
+80,666
New +$435K ﹤0.01% 5055
2024
Q3
Sell
-694,881
Closed -$5.09M 6336
2024
Q2
$5.09M Buy
694,881
+179,147
+35% +$1.56M ﹤0.01% 2712
2024
Q1
$5.16M Buy
+515,734
New +$4.51M ﹤0.01% 2837
2022
Q4
Sell
-650,935
Closed -$5.8M 6864
2022
Q3
$5.8M Buy
+650,935
New +$7.51M ﹤0.01% 2755

Other funds holding MSOS

Israel Englander's MSOS Position: Q2 2026 in Review

Israel Englander sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q2 2026, closing a stake of 339,474 shares — an estimated $1.21M sold.

Israel Englander first reported a position in MSOS in Q3 2022 and held it in 7 quarters. The position peaked at $5.8M in Q3 2022. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Israel Englander reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 339,474 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $1.21M.
  • Israel Englander first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2022 and held it in 7 quarters.
  • Israel Englander's AdvisorShares Pure US Cannabis ETF position peaked at $5.8M in Q3 2022.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.